Experience with intravenous immunoglobulin in severe childhood atopic dermatitis

Allergol Immunopathol (Madr). 2012 Mar-Apr;40(2):131-3. doi: 10.1016/j.aller.2011.04.007. Epub 2011 Aug 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Sublingual
  • Adolescent
  • Animals
  • Antigens, Dermatophagoides / adverse effects
  • Antigens, Dermatophagoides / immunology
  • Child
  • Dermatitis, Atopic / diagnosis
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / immunology*
  • Dermatitis, Atopic / physiopathology
  • Desensitization, Immunologic*
  • Disease Progression
  • Drug Resistance
  • Female
  • Humans
  • Immunoglobulin E / blood
  • Immunoglobulins, Intravenous / administration & dosage*
  • Immunoglobulins, Intravenous / adverse effects
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Male
  • Pyroglyphidae
  • Remission Induction
  • Young Adult

Substances

  • Antigens, Dermatophagoides
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Immunoglobulin E